AURORA, CO - DECEMBER 15: (EDITORIAL USE ONLY) Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech holds a dose of the Johnson & Johnson COVID-19 vaccine before it is administered in a clinical trial on December 15, 2020 in Aurora, Colorado. The Johnson & Johnson vaccine could be submitted for emergency use by late January and is the only vaccine among leading candidates given as a single dose. (Photo by Michael Ciaglo/Getty Images)

The Pfizer COVID-19 vaccine could soon be approved for children ages 12-15. Pfizer’s COVID-19 vaccine could be approved for younger patients as early as this week.

The FDA is reportedly set to authorize the vaccine for children between the ages of 12 and 15.  Currently, the vaccine is only authorized for people 16 and older.

This new age group would mean all high school-aged kids and a portion of middle schoolers would be able to be vaccinated.

Pfizer says the vaccine was 100% effective for children in that age range in clinical tests. No new or previously unreported side effects were discovered.  If approved, young people could start getting vaccinated by the end of this month.

Younger children tend to not be as susceptible to COVID and don’t seem to spread it often.

Do you think it’s important for kids to be vaccinated?